CEACAM5 and neoplasm: The mAb targeting carcinoembryonic antigen (CEA) of CRC epithelial cells functionalizes the surface of PLGA-PEG NPs, thus effectively delivering paclitaxel to tumor tissue for killing tumor cells [173].